MoFo Advises Proximal Ventures on $27.5 Million Debut Fund
Morrison Foerster advised Proximal Ventures on the close of its $27.5 million debut Fund I to invest in AI-native companies reshaping life sciences. Fund I invests in pre-seed and seed companies building AI-native infrastructure across the life sciences value chain, from discovery to market access. The fund is backed by strategic partners including Domino Lane, SignalFire, Kleiner Perkins, Bertelsmann Healthcare Investments, and PagsGroup.
Proximal invests in AI-native companies across the pharmaceutical value chain, from computational drug discovery to clinical development, manufacturing, and commercialization. Founded by Sahir Raoof, Proximal takes a hands-on approach from inception, helping founders validate ideas, refine go-to-market strategy, and connect with pharma executives, design partners, and customers, often before the company is incorporated.
The MoFo team was led by private funds partner Stephanie Thomas and corporate associate John Shawel.
Read Proximal’s press release.
Practices

